In Brief: Lobbyists, including from drug companies, non-profits and tech giants, ramped up spending in Q2 of this year to try to get changes to the American Data Privacy and Protection Act (ADPPA), which has been receiving bipartisan support to give US consumers new power to limit data collection and use

Concerns include that, 1) the ADPPA as a federal law would preempt state laws and provide weaker protections; 2) new data controls would hamper government access to deter major crimes; 3) there are too many loopholes in the law benefiting data brokers; and 4) placing limitations on the estimated $240 billion data market will severely hamper the use of third-party data for safety regulation – and also most importantly for advertising.